Treatment of Migraine With Phytocannabinoids, the Involvement of Endocannabinoids in Migraine, and Potential Mechanisms of Action
The American Migraine Foundation estimates that over 39 million Americans and over 1 billion people worldwide suffer from some form of migraine. Treatment of migraine generally falls into two categories: treatment of attacks once they have begun, and prophylactic prevention, including lifestyle chan...
Saved in:
| Main Author: | Roger Gregory Biringer |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Pain Research and Management |
| Online Access: | http://dx.doi.org/10.1155/prm/7181066 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Enhancement of the endocannabinoid system through monoacylglycerol lipase inhibition relieves migraine-associated pain in mice
by: Elizaveta Mangutov, et al.
Published: (2025-04-01) -
BIOFEEDBACK IN MIGRAINE TREATMENT
by: N. L. Starikova
Published: (2013-04-01) -
Migraine Pathophysiology and Treatment
by: J Gordon Millichap
Published: (1999-11-01) -
Exploring the Potential of Phytocannabinoids Against Multidrug-Resistant Bacteria
by: Carmina Sirignano, et al.
Published: (2025-06-01) -
Pharmacokinetics of Non-Psychotropic Phytocannabinoids
by: Mariana Lacerda, et al.
Published: (2025-02-01)